Futures on Wall Street have declined after a session that left the street disappointed. An appeals court reinstated the ...

A US federal court’s ruling late Wednesday against President Donald Trump’s authority to levy some of his most sweeping ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...

President Donald Trump’s proposal to peg US drug prices to those paid abroad includes granting the FDA legal authority to ...

By comparison, just 5.4% of shipments from top US solar component suppliers Malaysia ... any solar panels from India. The increased scrutiny of Indian shipments reflects the border agency ...

ONE of the assumed pressure points in the ongoing nonviolent dispute between the United States and China is the latter's ...

Alibaba Group Holding’s wholesale marketplace has briefly topped the shopping app charts in the US, as American consumers hunt for bargains amid fears of rising prices. Alibaba.com, the e ...

Alibaba Group Holding Limited (NYSE:BABA) found itself on the wrong side of government scrutiny in late 2020, which forced the company to delay the public listing of its financial services ...

Investing.com -- US-listed Chinese stocks rebounded on Tuesday, with Alibaba (NYSE ... This brought back memories of 2022 when heightened scrutiny of Chinese companies sparked fears of potential ...

Alibaba plans to invest $53 billion in AI and cloud over the next three years as it competes with US tech giants. Hot stock Alibaba has set its sights beyond AI to focus on artificial general ...

In a significant escalation of transatlantic tensions over tech regulation, US House Judiciary Chairman ... s recent memorandum announcing heightened scrutiny of the EU’s Digital Markets Act ...